A National Cancer Database analysis of 7,285 patients under 50 who underwent surgery for rectal neuroendocrine neoplasms found that annual cases increased from 234 in 2004 to 778 in 2023, with 91% undergoing local excision and 83% of tumors being low grade, compatible with increased detection of indolent lesions through greater endoscopic evaluation. (Am Surg)
Surgically treated early-onset rectal neuroendocrine neoplasms increased from 234 to 778 cases annually
The CRC Digest